119 related articles for article (PubMed ID: 38501453)
1. Longitudinal comparison of the self-administered ALSFRS-RSE and ALSFRS-R as functional outcome measures in ALS.
Erb MK; Calcagno N; Brown R; Burke KM; Scheier ZA; Iyer AS; Clark A; Higgins MP; Keegan M; Gupta AS; Johnson SA; Chew S; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Mar; ():1-11. PubMed ID: 38501453
[No Abstract] [Full Text] [Related]
2. Longitudinal comparison of the self-entry Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-RSE) and Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) as outcome measures in people with amyotrophic lateral sclerosis.
Johnson SA; Burke KM; Scheier ZA; Keegan MA; Clark AP; Chan J; Fournier CN; Berry JD
Muscle Nerve; 2022 Oct; 66(4):495-502. PubMed ID: 35904151
[TBL] [Abstract][Full Text] [Related]
3. Remote digital assessment of amyotrophic lateral sclerosis functional rating scale - a multicenter observational study.
Meyer T; Spittel S; Grehl T; Weyen U; Steinbach R; Kettemann D; Petri S; Weydt P; Günther R; Baum P; Schlapakow E; Koch JC; Boentert M; Wolf J; Grosskreutz J; Rödiger A; Ilse B; Metelmann M; Norden J; Koc RY; Körtvélyessy P; Riitano A; Walter B; Hildebrandt B; Schaudinn F; Münch C; Maier A
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):175-184. PubMed ID: 35912984
[TBL] [Abstract][Full Text] [Related]
4. Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures.
Johnson SA; Karas M; Burke KM; Straczkiewicz M; Scheier ZA; Clark AP; Iwasaki S; Lahav A; Iyer AS; Onnela JP; Berry JD
NPJ Digit Med; 2023 Mar; 6(1):34. PubMed ID: 36879025
[TBL] [Abstract][Full Text] [Related]
5. Design and results of a smartphone-based digital phenotyping study to quantify ALS progression.
Berry JD; Paganoni S; Carlson K; Burke K; Weber H; Staples P; Salinas J; Chan J; Green JR; Connaghan K; Barback J; Onnela JP
Ann Clin Transl Neurol; 2019 May; 6(5):873-881. PubMed ID: 31139685
[TBL] [Abstract][Full Text] [Related]
6. Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale.
Chew S; Burke KM; Collins E; Church R; Paganoni S; Nicholson K; Babu S; Scalia JB; De Marchi F; Ellrodt AL; Moura LMVR; Chan J; Berry JD
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):467-477. PubMed ID: 33771057
[No Abstract] [Full Text] [Related]
7. Tracking amyotrophic lateral sclerosis disease progression using passively collected smartphone sensor data.
Karas M; Olsen J; Straczkiewicz M; Johnson SA; Burke KM; Iwasaki S; Lahav A; Scheier ZA; Clark AP; Iyer AS; Huang E; Berry JD; Onnela JP
Ann Clin Transl Neurol; 2024 Jun; 11(6):1380-1392. PubMed ID: 38816946
[TBL] [Abstract][Full Text] [Related]
8. ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale.
Maier A; Boentert M; Reilich P; Witzel S; Petri S; Großkreutz J; Metelmann M; Lingor P; Cordts I; Dorst J; Zeller D; Günther R; Hagenacker T; Grehl T; Spittel S; Schuster J; Ludolph A; Meyer T;
Neurol Res Pract; 2022 Dec; 4(1):60. PubMed ID: 36522775
[TBL] [Abstract][Full Text] [Related]
9. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R.
Bakker LA; Schröder CD; Tan HHG; Vugts SMAG; van Eijk RPA; van Es MA; Visser-Meily JMA; van den Berg LH
J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):75-81. PubMed ID: 31558653
[TBL] [Abstract][Full Text] [Related]
10. [Development of a telephone survey system for patients with amyotrophic lateral sclerosis using the ALSFRS-R (Japanese version) and application of this system in a longitudinal multicenter study].
Atsuta N; Watanabe H; Ito M; Nakamura R; Senda J; Kato S; Sobue G
Brain Nerve; 2011 May; 63(5):491-6. PubMed ID: 21515929
[TBL] [Abstract][Full Text] [Related]
11. The frequency of ALSFRS-R reversals and plateaus in patients with limb-onset amyotrophic lateral sclerosis: a cohort study.
Hu N; Shen D; Yang X; Cui L; Liu M
Acta Neurol Belg; 2022 Dec; 122(6):1567-1573. PubMed ID: 35034333
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
;
Lancet Neurol; 2017 Jul; 16(7):505-512. PubMed ID: 28522181
[TBL] [Abstract][Full Text] [Related]
13. Clinically meaningful change: evaluation of the Rasch-built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) and the ALSFRS-R.
Fournier CN; James V; Glass JD
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):311-316. PubMed ID: 36476010
[TBL] [Abstract][Full Text] [Related]
14. Remote-Use Applications of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised Clinical Outcome Assessment Tool: A Scoping Review.
Bhushan NL; Romano CD; Gras-Najjar J; Reno J; Rockwood N; Quattrone W; Adams ET; Kelly B; McLeod L; Bhavnani SP; Bocell FD; Campbell M; Kontson K; Reasner D; Zhang C; Retzky S
Value Health; 2024 May; ():. PubMed ID: 38795957
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Measurement Properties of the Self-Administered Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R): A Rasch Analysis.
Mehdipour A; Teshler L; Dal Bello-Haas V; Richardson J; Beauchamp M; Turnbull J; Chum M; Johnston W; O'Connell C; Luth W; Kuspinar A
Phys Ther; 2023 Nov; 103(11):. PubMed ID: 37581600
[TBL] [Abstract][Full Text] [Related]
16. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.
Pratap A; Grant D; Vegesna A; Tummalacherla M; Cohan S; Deshpande C; Mangravite L; Omberg L
JMIR Mhealth Uhealth; 2020 Oct; 8(10):e22108. PubMed ID: 33107827
[TBL] [Abstract][Full Text] [Related]
18. Upper limb movements as digital biomarkers in people with ALS.
Straczkiewicz M; Karas M; Johnson SA; Burke KM; Scheier Z; Royse TB; Calcagno N; Clark A; Iyer A; Berry JD; Onnela JP
EBioMedicine; 2024 Mar; 101():105036. PubMed ID: 38432083
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers.
Manera U; Solero L; Fournier CN; Canosa A; Vasta R; Bombaci A; Grassano M; Palumbo F; Torrieri MC; Salamone P; Casale F; Fuda G; Moglia C; Calvo A; Chiò A
Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug; 23(5-6):424-429. PubMed ID: 34894916
[No Abstract] [Full Text] [Related]
20. Automated speech analytics in ALS: higher sensitivity of digital articulatory precision over the ALSFRS-R.
Stegmann G; Krantsevich C; Liss J; Charles S; Bartlett M; Shefner J; Rutkove S; Kawabata K; Talkar T; Berisha V
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Jun; ():1-9. PubMed ID: 38932502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
